In silico, in vitro and in vivo analyses of dipeptidyl peptidase IV inhibitory activity and the antidiabetic effect of sodium caseinate hydrolysate

Food and Function

Volumn 7, Issue 2, 2016, Pages 1122-1128

  Hsieh, Cheng Hong ^a   Wang, Tzu Yuan ^b   Hung, Chuan Chuan ^a,c   Jao, Chia Ling ^d   Hsieh, You Liang ^a   Wu, Si Xian ^c   Hsu, Kuo Chiang ^a,c  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d Tung Fang Design Institute   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; HYDROLYSIS; PEPTIDES; PROTEOLYSIS; RATS; SODIUM;

ANTIDIABETIC EFFECTS; CONSTITUENT PROTEINS; DIETARY PROTEINS; DIPEPTIDYL PEPTIDASE IV; INHIBITORY ACTIVITY; PEPTIDE FRAGMENTS; SODIUM CASEINATE; STREPTOZOTOCIN;

PROTEINS;

ANTIDIABETIC AGENT; BROMELAIN; CASEIN; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE BLOOD LEVEL; PEPTIDE FRAGMENT; PROTEINASE; STREPTOZOCIN;

ANIMAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE BLOOD LEVEL; LIPID DIET; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BROMELAINS; CASEINS; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; ENDOPEPTIDASES; HYPOGLYCEMIC AGENTS; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 84959370147     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c5fo01324k     Document Type: Article

References (32)

1. S. Wild G. Roglic A. Green R. Sicree H. King Global prevalence of diabetes estimates from the year 200 and projections for 2030 Diabetes Care 2004 27 1047 1053
2. L. Juillerat-Jeanneret Dipeptidyl peptidase IV and its inhibitors: Therapeutics for type 2 diabetes and what else? J. Med. Chem. 2014 57 2197 2212
3. D. F. Cunningham B. O'Connor Proline specific peptidases Biochim. Biophys. Acta 1997 1343 160 186
4. J. J. Holst C. F. Deacon Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus Curr. Opin. Pharmacol. 2004 4 589 596
5. C. F. Deacon M. A. Nauck J. Meier K. Hücking J. J. Holst Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabeic subjects as revealed using a new assay for the intact peptide J. Clin. Endocrinol. Metab. 2000 85 3575 3581
6. H. Mitani M. Takimoto T. E. Hughes M. Kimura Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity Jpn. J. Pharmacol. 2002 88 442 450
7. K. Gooben S. Gräber Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis Diabetes, Obes. Metab. 2012 14 1061 1072
8. I. M. E. Lacroix E. C. Y. Li-Chan Isolation and characterization of peptides with dipeptidyl peptidase-IV inhibitory activity from pepsin-treated bovine whey proteins Peptides 2014 54 39 48
9. A. B. Nongonierma R. J. FitzGerald Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis Food Chem. 2014 145 845 852
10. T. Hatanaka Y. Inoue J. Arima Y. Kumagai H. Usuki K. Kawakami M. Kimura T. Mukaihara Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran Food Chem. 2012 134 797 802
11. A. J. Velarde-Salcedo A. Barrera-Pacheco S. Lara-González G. M. Montero-Morán A. Díaz-Gois E. González de Mejia A. Barba de la Rosa In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins Food Chem. 2013 136 758 764
12. E. C. Y. Li-Chan S. L. Huang C. L. Jao K. P. Ho K. C. Hsu Peptides derived from Atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors J. Agric. Food Chem. 2012 60 973 978
13. S. L. Huang C. L. Jao K. P. Ho K. C. Hsu Dipeptidyl-peptidase IV inhibitory activity of peptides from tuna cooking juice hydrolysates Peptides 2012 35 114 121
14. C. H. Hsieh T. Y. Wang C. C. Hung M. C. Chen K. C. Hsu Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor Food Funct. 2015 6 1887 1892
15. S. L. Huang C. C. Hung C. L. Jao Y. S. Tung K. C. Hsu Porcine skin gelatin hydrolysate as a dipeptidyl peptidase IV inhibitor improves glycemic control in streptozotocin-induced diabetic rats J. Funct. Foods 2014 11 235 242
16. I. M. Lacroix E. C. Li-Chan Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates Int. Dairy J. 2012 25 97 102
17. A. B. Nongonierma R. J. FitzGerald An in silico model to predict the potential of dietary proteins as sources of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides Food Chem. 2014 165 489 498
18. A. Davy K. K. Thomsen M. A. Juliano L. C. Alves I. Svendsen D. J. Simpson Purification and characterization of barley dipeptidyl peptidase IV Plant Physiol. 2000 122 425 431
19. P. Minkiewicz J. Dziuba J. Michalska Bovine meat proteins as potential precursors of biologically active peptides - A computational study based on the BIOPEP database Food Sci. Technol. Int. 2011 17 39 45
20. J. Alder-Nissen, Enzyme hydrolysis of food proteins, Elsevier Applied Science Publisher, New York, 1986
21. K. Kojima T. Ham T. Kato Rapid chromatographic purification of dipeptidyl peptidase IV in human submaxiallry gland J. Chromatogr. 1980 189 233 240
22. K. Srinivasan B. Viswanad L. Asrat C. L. Kaul P. Ramarao Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacol. Res. 2005 52 313 320
23. P. Murugan L. Pari Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats Life Sci. 2006 79 1720 1728
24. T. Sipos J. R. Merkel An effect of calcium ions on the activity, heat stability, and structure of trypsin Biochemistry 1970 9 2766 2775
25. V. A. Aart, M. J. Catharina, V. Zeeland-Wolbers, L. A. Maria, V. Gilst, W. Hendrikus, B. J. H. Nelissen and J. W. P. Maria, Egg protein hydrolysates, WO 2009/128713, 2009
26. B. J.-W. Pieter, Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use, WO 2006/068480, 2006
27. T. Y. Wang C. H. Hsieh C. C. Hung C. L. Jao M. C. Chen K. C. Hsu Fish skin gelatin hydrolysates as dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 stimulators improve glycaemic control in diabetic rats: a comparison between warm- and cold-water fish J. Funct. Foods 2015 19 330 340
28. A. Holmes L. J. Coppey E. P. Davidson M. A. Yorek Rat models of diet-induced obesity and high fat/low dose streptozotocin type 2 diabetes: effect of reversal of high fat diet compared to treatment with enalapril or menhaden oil on glucose utilization and neuropathic endpoints J. Diabetes Res. 2015 10.1155/2015/307285
29. Y. Wang T. Campbell B. Perry C. Beaurepaire L. Qin Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats Metabolism 2011 60 298 305
30. X. K. Zheng L. Zhang W. W. Wang Y. Y. Wu Q. B. Zhang W. S. Feng Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) spring in rats induced by high fat diet and low dose STZ J. Ethnopharmacol. 2011 137 662 668
31. S. J. Kim C. Nian D. J. Doudet C. H. S. McIntosh Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice Diabetes 2008 57 1331 1339
32. J. A. Pospisilik S. G. Stafford H. U. Demuth C. H. S. McIntosh R. A. Pederson Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat Diabetes 2002 51 2677 2683